Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 26;13:1063183. doi: 10.3389/fonc.2023.1063183

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Tang, Ye, Tang, Su, Xu, Zhong and Liang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Summary of survival rates of clinical trials. (A) 3-year disease-free survival rates and 5-year overall survival rates of patients with stage II-IIIA non–small cell lung cancer in the IMpower010 trial. (B) 3-year disease-free survival rates of patients with stage IB-IIIA non-small cell lung cancer in the IMpower010 and KEYNOTE-091 trials. ALK, anaplastic lymphoma kinase; Chemo, chemotherapy; DFS, disease-free survival; EGFR, epidermal growth factor receptor; OS, overall survival; PD-L1, programmed death-ligand 1.